Charles River Laboratories International Inc. Stock Rises 6.2%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Charles River Laboratories International Inc. advanced 6.2% to $294.44 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 7,704.13 and the Dow Jones Industrial Average falling 0.3% to 51,349.98.

Charles River Laboratories International Inc. closed 2.9% short of its 52-week high of $303.31, which the company reached on August 27th.

The stock outperformed some of its peers, as Labcorp Holdings Inc. rose 1.6% to $308.95, Alnylam Pharmaceuticals Inc. rose 1.2% to $249.59, and Bio-Techne Corp. rose 0.07% to $72.57.

Trading volume totaled 1.6 million, compared to the 50-day average of 934,933.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 24, 2026 16:33 ET (20:33 GMT)